StonvexLoading…
StonvexStonvexStonvexCore line items from TKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2024 2024-09-30 | Annual 2024 2024-06-30 |
|---|---|---|---|---|
Revenue | $4.58B | $4.57B | $1.13B | $1.18B |
Operating Income | $540.60M | $611.10M | $146.30M | $167.20M |
Net Income | $288.40M | $352.70M | $81.80M | $96.20M |
EPS (Diluted) | $4.11 | $4.99 | $1.16 | $1.36 |
Total Assets | $6.68B | $6.41B | Not available | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $364.40M | $373.20M | Not available | Not available |
Free Cash Flow OCF − CapEx | $406.10M | $305.70M | Not available | Not available |
Shares Outstanding | 70.23M | 70.75M | Not available | Not available |